129 related articles for article (PubMed ID: 34132827)
1. [Results of the RAPIDO randomized study on total neoadjuvant treatment of rectal cancer].
Germer CT; Reibetanz J
Chirurg; 2021 Jul; 92(7):666. PubMed ID: 34132827
[No Abstract] [Full Text] [Related]
2. Total neoadjuvant therapy for rectal cancer: here and now.
Sammour T
ANZ J Surg; 2021 Jan; 91(1-2):12-13. PubMed ID: 32857897
[No Abstract] [Full Text] [Related]
3. Neoadjuvant Therapy for cT2N0M0 Rectal Cancer?
Rubio GA; Hurst RD; Umanskiy K; Shogan BD; Hyman N; Olortegui KS
J Gastrointest Surg; 2022 Feb; 26(2):479-482. PubMed ID: 34506020
[No Abstract] [Full Text] [Related]
4. Total pelvic resection for locally advanced rectal cancer after failure of neoadjuvant therapy - a video vignette.
Chen J; Ye K; Wu C; Wang J; Lin J; Zhong W
Colorectal Dis; 2023 Aug; 25(8):1736-1738. PubMed ID: 37461271
[No Abstract] [Full Text] [Related]
5. Should the RAPIDO schedule represent standard of care in locally advanced rectal cancer?
Glynne-Jones R; Harrison M
Ann Oncol; 2022 Aug; 33(8):745-746. PubMed ID: 35568280
[No Abstract] [Full Text] [Related]
6. A surgical perspective on total neoadjuvant therapy for rectal cancer: Shades and lights of a new journey.
Spinelli A; Carvello M
Colorectal Dis; 2021 Sep; 23(9):2223-2224. PubMed ID: 34515403
[No Abstract] [Full Text] [Related]
7. Application value of biplane transrectal ultrasonography plus ultrasonic elastosonography and contrast-enhanced ultrasonography in preoperative T staging after neoadjuvant chemoradiotherapy for rectal cancer.
Xiao Y; Xu D; Ju H; Yang C; Wang L; Wang J; Hazle JD; Wang D
Eur J Radiol; 2018 Jul; 104():20-25. PubMed ID: 29857861
[TBL] [Abstract][Full Text] [Related]
8. Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials.
Giunta EF; Bregni G; Pretta A; Deleporte A; Liberale G; Bali AM; Moretti L; Troiani T; Ciardiello F; Hendlisz A; Sclafani F
Cancer Treat Rev; 2021 May; 96():102177. PubMed ID: 33798955
[TBL] [Abstract][Full Text] [Related]
9. Timing of rectal cancer surgery following neoadjuvant chemoradiation: how close are we to striking an equipoise?
Barreto SG; Sirohi B; Shrikhande SV
Future Oncol; 2017 Feb; 13(4):303-305. PubMed ID: 27875904
[No Abstract] [Full Text] [Related]
10. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
[TBL] [Abstract][Full Text] [Related]
11. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
12. Local Excision Techniques for Rectal Cancer After Neoadjuvant Chemoradiotherapy: What Are We Doing?
Smith FM; Ahad A; Perez RO; Marks J; Bujko K; Heald RJ
Dis Colon Rectum; 2017 Feb; 60(2):228-239. PubMed ID: 28059920
[TBL] [Abstract][Full Text] [Related]
13. Do We Have Enough Evidence to Propose a Preferred Total Neoadjuvant Therapy Sequence for Patients With Locally Advanced Rectal Cancer?
Siegel R
JAMA Oncol; 2022 May; 8(5):781-782. PubMed ID: 35357411
[No Abstract] [Full Text] [Related]
14. Endorectal ultrasonography performance in staging rectal cancer before and after neoadjuvant chemoradiotherapy.
Panzironi G; Guerrieri D; De Cristofaro F; Bangrazi C; Di Paola C; Jafari L; Fiore F; Masoni L
Ann Ital Chir; 2014; 85(6):569-75. PubMed ID: 25711540
[TBL] [Abstract][Full Text] [Related]
15. Near-complete response following neoadjuvant therapy in rectal cancer: resect now?
Perez RO; Cerdán-Santacruz C; São Julião GP
Br J Surg; 2023 Jul; 110(8):936-937. PubMed ID: 37279948
[No Abstract] [Full Text] [Related]
16. [Full thickness wall resection vs. TME in patients with complete remission after neoadjuvant chemoradiotherapy].
Straßmüller A; Anthuber M
Chirurg; 2020 Nov; 91(11):975. PubMed ID: 33052415
[No Abstract] [Full Text] [Related]
17. Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome.
Wolthuis AM; Penninckx F; Haustermans K; De Hertogh G; Fieuws S; Van Cutsem E; D'Hoore A
Ann Surg Oncol; 2012 Sep; 19(9):2833-41. PubMed ID: 22451236
[TBL] [Abstract][Full Text] [Related]
18. Preoperative versus pathological staging of rectal cancer-challenging the indication of neoadjuvant chemoradiotherapy.
Fritz S; Killguss H; Schaudt A; Lazarou L; Sommer CM; Richter GM; Küper-Steffen R; Feilhauer K; Köninger J
Int J Colorectal Dis; 2021 Jan; 36(1):191-194. PubMed ID: 32955607
[TBL] [Abstract][Full Text] [Related]
19. [Neoadjuvant treatment as a limiting factor to rectal ultrasonography].
Fábián A; Bor R; Bálint A; Farkas K; Milassin Á; Rutka M; Tiszlavicz L; Nagy F; Molnár T; Szepes Z
Orv Hetil; 2016 Jul; 157(30):1193-7. PubMed ID: 27452069
[TBL] [Abstract][Full Text] [Related]
20. [Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery].
Scutari F; Tramutola G; Morlino A; Rossi MT; Manzione L; Rosati G; Sopranzi A
G Chir; 2008; 29(6-7):277-80. PubMed ID: 18544264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
